Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Enrollment complete for phase III clinical trial of pravastatin combination therapy

Oct. 16, 2007

Desvenlafaxine improves hot flushes, mood in postmenopausal women

Oct. 16, 2007

Orphan Europe seeks EMEA approval of Vedrop for vitamin E deficiencies

Oct. 16, 2007

A farnesoid X receptor agonist for the treatment of dyslipidemia

Oct. 15, 2007

Novel treatment options for obesity and other metabolic disorders described in recent patents

Oct. 15, 2007

NIH to sponsor preclinical DT-22669 diabetes study

Oct. 15, 2007

Amarin initiates cardiovascular development strategy

Oct. 15, 2007

Recent patents describe new antidiabetic agents

Oct. 15, 2007

AEGR-733 lowers LDL-cholesterol, body weight in hypercholesterolemic patients

Oct. 15, 2007

MK-0859 improves LDL- and HDL-cholesterol in large dyslipidemia study

Oct. 11, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...